Experiences and Perceptions of Cervical Cancer Screening Using Self-Sampling among Under-Screened Women in Flanders.

HPV barriers and facilitators cervical cancer screening self-sampling

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
26 Aug 2024
Historique:
received: 22 07 2024
revised: 18 08 2024
accepted: 22 08 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 14 9 2024
Statut: epublish

Résumé

Primary Human Papillomavirus (HPV) screening on samples collected by women themselves has proven to be an effective strategy for cervical cancer screening (CCS) and may increase participation rates in women who do not partake (regularly) in screening. The aim of this study is to investigate reasons for non-participation and perceptions of CCS using self-sampling methods among under-screened women in Flanders. Individual interviews with 15 underscreened women aged 30-64 years were conducted. During the interviews, participants were given the opportunity to try out a urine and vaginal self-sampling kit. Thematic analysis was based on Ajzen's model of the Theory of Planned Behavior. The results showed that 14 out of 15 participants were more likely to participate in CCS if they had the option to self-sample. One of the main findings was a lack of knowledge on different aspects of cervical cancer. Most women had a positive attitude toward cancer screening and primary prevention such as HPV vaccination. Subjective norms were influenced by healthcare professionals, peers, and organized government initiatives. Informational, organizational, contextual, and emotional factors were mentioned as barriers as well as facilitators for participation. Additionally, high self-efficacy was considered to make self-sampling more convenient. All women showed the intention to use at least one method of self-sampling. We can conclude that women who do not participate in CCS would be more motivated to participate using self-sampling methods. Adequate education and guidance should be provided.

Identifiants

pubmed: 39273727
pii: healthcare12171704
doi: 10.3390/healthcare12171704
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Research Foundation - Flanders
ID : T004921N; ScreenUrSelf trial

Auteurs

Charlotte Buelens (C)

Department of Family Medicine and Population Health, Primary and Interdisciplinary Care Antwerp, University of Antwerp, 2610 Antwerp, Belgium.

Margot Stabel (M)

Department of Family Medicine and Population Health, Primary and Interdisciplinary Care Antwerp, University of Antwerp, 2610 Antwerp, Belgium.

Alice Wildiers (A)

Department of Family Medicine and Population Health, Primary and Interdisciplinary Care Antwerp, University of Antwerp, 2610 Antwerp, Belgium.

Lieve Peremans (L)

Department of Family Medicine and Population Health, Primary and Interdisciplinary Care Antwerp, University of Antwerp, 2610 Antwerp, Belgium.

Guido Van Hal (G)

Department of Family Medicine and Population Health, University of Antwerp, 2610 Antwerp, Belgium.

Lotje Van Doorsselaere (L)

Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, 2650 Antwerp, Belgium.

Annouk Lievens (A)

Marketing Department, Faculty of Business and Economics, University of Antwerp, 2000 Antwerp, Belgium.
U-MaMi Consortium, 2020 Antwerp, Belgium.

Alex Vorsters (A)

Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, 2650 Antwerp, Belgium.

Severien Van Keer (S)

Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, 2650 Antwerp, Belgium.

Veronique Verhoeven (V)

Department of Family Medicine and Population Health, Primary and Interdisciplinary Care Antwerp, University of Antwerp, 2610 Antwerp, Belgium.
U-MaMi Consortium, 2020 Antwerp, Belgium.

Classifications MeSH